🔗 Share this article

As America undertakes unprecedented adjustments to its vaccine recommendations, a particular individual appears unexpectedly: Dr. Tracy Beth Høeg, an American of Danish descent sports physician and epidemiologist who first made her name by questioning Covid shots in the global health crisis and has concentrated on alleged fatalities following Covid vaccination in her recent position at the Food and Drug Administration.

Scheduled Overhauls to Childhood Immunization Schedule

Health officials planned to reveal radical revisions to the childhood immunization program in December, synchronizing the US with Denmark’s national calendar, according to reports – a substantial departure that would place the US out of alignment with many the world with no evidence for benefit. The announcement has been delayed until the coming year.

Rather than Vinay Prasad, Dr. Høeg is scheduled to speak at the event. She was recently named acting director of the FDA’s CDER, the fifth individual to lead the office this year.

Consolidating Power at the FDA

The acting appointment may indicate a closer partnership between the pharmaceutical and biologics centers as Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it suggests a greater focus upon dismantling already-approved vaccines at the FDA.

Høeg has frequently advocated for ending some childhood vaccine recommendations in the US so as to align more in line with Denmark, a society with nationalized medicine and a citizenry roughly the size of the state of Wisconsin.

So far statements, she has persisted in emphasizing on vaccines – traditionally the responsibility of Prasad, chief of the FDA’s vaccine center – as opposed to drug regulation.

Questions Over Qualifications

The appointee has no apparent experience in medication creation, regulation or management, which has been typical for past directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a key advisor to the FDA chief and CBER since spring.

“It seems she lacks to have the requisite experience” for leading the CDER, said Dr. Jonathan Howard. “She lacks experience running a randomized controlled trial. She is not versed in leading a large organization. She is not an expert in pharmaceutical oversight.”

Previous directors of the center would “grasp laws and regulations and the science of pharmaceutical innovation”, commented Dr. Janet Woodcock. “Clearly, she lacks the kind of background that previous people who headed CBER have had.”

The drug center has an enormous workload at the agency, Woodcock emphasized.

“Many people just zeroes in on the novel medication approvals, but the generic program approves a multitude of generic medications. There’s a biosimilars program, over-the-counter program and more, and every single one need to be looked after,” she said. “The area you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Furthermore, a major management element to the position, which oversees more than 5,000 personnel. “It is a massive management job, if you execute it properly,” the former official said.

Response and Controversial Programs

Regarding questions about Høeg’s credentials and whether this assignment signifies more teamwork among agency officials on immunizations, a spokesperson responded that the “concerns stem from incorrect presumptions”.

“Her experience matches the responsibilities of her role,” the representative explained, citing the months Dr. Høeg spent counseling the agency head on “medication safety and regulatory science, including computational safety modeling and shot safety tracking”.

In her interim role, Dr. Høeg takes over the commissioner’s controversial expedited review system, a contentious rapid medication authorization process that reportedly concerned her former heads. “By what process are these medications being selected for this fast-track system? Who takes the choices?” Howard asked. “There’s a lot of confidentiality going on at the regulatory body right now.”

In general, he said, “the Food and Drug Administration appears to be shifting towards less stringent oversight of pharmaceuticals, aside from immunizations.”

Documented History on Immunizations

Concerning immunizations, Dr. Høeg has a clearer, if troubling, history, critics have noted. She released a analysis using non-validated public submissions to assess the rate of myocarditis after COVID-19 vaccination. She advised the Florida surgeon general Dr. Joseph Ladapo, who reportedly have altered data to suggest Covid vaccines are riskier than they are.

Included in her “policy goals” for the current government included revising regulations for new vaccines and ending “non-essential” vaccines, she stated post-election on a podcast. At the agency, Dr. Høeg has allegedly proposed barring teenage boys from getting Covid vaccinations.

“She’s an thorough ideologue who starts off with her conclusions and works backwards to fit the science in a extremely deceptive, fraudulent way,” Howard said.

Taking Control and a “Revenge Tour”

Høeg became part of other dissenters, {like|